课题基金 / 基金详情

MUCOSAL IMMUNIZATION USING AN H PYLORI UREASE

MUCOSAL IMMUNIZATION USING AN H PYLORI UREASE
使用幽门螺杆菌脲酶进行粘膜免疫
批准号:
2420488
负责人:
DEBRA J TRANTOLO
金额:
$10.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-07-01 至 1997-12-31

项目摘要

项目成果

DEBRA J TRANTOLO的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Currently, the practical administration of miroparticles as carriers for the delivery of oral vaccine preparations is limited due to the poor efficiency of particle sampling by the GI tract. The addition of bioadhesive properties to vaccine carriers may increase the efficiency of sampling thereby reducing the doses required to achieve effective vaccination. It is believed that immunogenic molecules which readily bind to the surface of gut epithelial cells stimulate a stronger immune response than non-adherent molecules. This is likely due to enhanced sampling of adherent immunogens by M cells overlying intestinal lymphoid follicles, which ar specialized for antigen sampling and transport to mucosal antibody inductive sites. In preliminary studies, we have examined the ability of various bioadhesive compounds to enhance the binding and sampling of poly(lactic-co-glycolic) acid (PLGA) microparticles in mouse Peyer's patch (PP) tissue. We now have a quantitative tool to correlate optimization of particle uptake with the development of an immune response. The proposed Phase I project will now directly compare these improvements in particle uptake with immunogenicity to quantitatively determine the correlation between uptake and th development of immunity. They proposed work uses a candidate vaccine antigen against Helicobacter pylori, which is the principal case of peptic ulcer disease and chronic (type B) gastritis, and has been strongly implicated as co-factor in the genesis of gastric cancer. The strategies developed with this well-characterized system can potentially be applied to other antigens, as well. PROPOSED COMMERCIAL APPLICATION: The development of vaccine carriers for oral delivery presents a significant challenge for vaccine technology. Oral immunization is a more convenient and safer, and mucosal immunization is more efficient for eliciting secretory immune responses. Many vaccine manufacturers would be a potential commercial market for development/utilization of this technology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Biodegradable Bone Graft Extender
  • 批准号:
    6646230
  • 项目类别:
  • 资助金额:
    $41.14万
  • 财政年份:
    2003
  • 负责人:
    DEBRA J TRANTOLO
  • 依托单位:
DNA Plasmid Mucosally Enhanced Anthrax Delivery Vaccine
  • 批准号:
    6555371
  • 项目类别:
  • 资助金额:
    $12.5万
  • 财政年份:
    2002
  • 负责人:
    DEBRA J TRANTOLO
  • 依托单位:
NANO-HYDROXYAPATITE IN BIOPOLYMERIC SCAFFOLDS FOR BONE
  • 批准号:
    6497907
  • 项目类别:
  • 资助金额:
    $10.22万
  • 财政年份:
    2001
  • 负责人:
    DEBRA J TRANTOLO
  • 依托单位:
Polymeric Reinforcement of Degradable Bone Plates
  • 批准号:
    6402333
  • 项目类别:
  • 资助金额:
    $10.0万
  • 财政年份:
    2001
  • 负责人:
    DEBRA J TRANTOLO
  • 依托单位:
海外基金